Publikationen von Peggy Kaiser
Alle Typen
Zeitschriftenartikel (10)
2021
Zeitschriftenartikel
Role of Premycofactocin Synthase in Growth, Microaerophilic Adaptation, and Metabolism of Mycobacterium tuberculosis. mBio, e0166521 (2021)
2020
Zeitschriftenartikel
13 (3), dmm041954 (2020)
FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity. Disease Models & Mechanisms 2019
Zeitschriftenartikel
10 (3), e00190-19 (2019)
Mycofactocin Is Associated with Ethanol Metabolism in Mycobacteria. mBio
Zeitschriftenartikel
10, 89 (2019)
Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens. Frontiers in immunology 2018
Zeitschriftenartikel
4 (11), S. 1623 - 1634 (2018)
Phagosomal Copper-Promoted Oxidative Attack on Intracellular Mycobacterium tuberculosis. ACS Infectious Diseases 2017
Zeitschriftenartikel
7 (1), 8853 (2017)
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans. Scientific Reports 2016
Zeitschriftenartikel
7 (3), e00679-16 (2016)
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. mBio
Zeitschriftenartikel
18 (5), S. 364 - 368 (2016)
Post-exposure vaccination with the vaccine candidate Bacillus Calmette–Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis. Microbes and Infection 2014
Zeitschriftenartikel
5 (3), e01262-14 (2014)
Dietary Pyridoxine Controls Efficacy of Vitamin B6-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice. mBio 2013
Zeitschriftenartikel
8 (11), e78966 (2013)
The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice. PLoS One